UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000012146
Receipt number R000014189
Scientific Title A multi-center double-blind parallel-group placebo-control Phase II study on the efficacy of survivin-2B peptide vaccine therapy for patients with advanced or recurrent pancreatic cancer, and for which there is no effective treatment.
Date of disclosure of the study information 2013/11/01
Last modified on 2018/11/26 11:00:22

No. Disposal Last modified on Item of update
1 Insert 2013/10/28 14:38:42
2 Update 2013/10/28 16:34:19 Acronym
Acronym
3 Update 2015/09/28 14:19:30 Division name
Division name
Division name
Division name
Division name
Co-sponsor
Co-sponsor
Institutions
4 Update 2015/10/21 11:54:33 Organization
Organization
Category of Funding Organization
5 Update 2016/06/16 17:46:50 Recruitment status
6 Update 2017/01/01 07:18:34 Last follow-up date
Date trial data considered complete
7 Update 2018/06/06 17:02:16 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
8 Update 2018/11/26 11:00:22 Publication of results